Press Release 30 January, 2023

Scandinavian Realheart AB ("Realheart" or the "Company"), issued during the third quarter of 2021 warrants of series 2021/2023 TO1 ("TO1"). The subscription period will start soon and run from February 1-28, 2023, during which four (4) warrants of series TO1 will entitle to subscribe for one (1) share in Realheart. The subscription price for one new share has been set at 3.37 in accordance with the terms of the option.

A total of 10,250,002 warrants of series TO1 are issued. Upon full exercise of the warrants, the number of shares in the company will increase by 2,562,500 shares to 35 745 961 shares, corresponding to a dilution effect of approximately 7.2 percent of the capital and votes of Realheart.

Subscription instructions

Holders whose warrants are registered with a trustee (i.e. the warrants are held in a share deposit account, ISK account or endowment insurance) subscribe and make payment in accordance with the instructions of their bank or other trustee. If you have any questions, please contact your bank/trustee well in advance of Tuesday 28 February 2022, as different trustees have different processing times.

Directly registered holders (holding on VP account) of warrants of series TO1 must notify the redemption of warrants by completing and submitting the notification form for redemption of TO1, so that it is received by the issuing institution Nordic Issuing no later than 3:00 p.m. on 28 February 2022. The notification form for directly registered holders can be downloaded from Nordic Issuing's website, https://nordic-issuing.se/

Issue and delivery of new shares

The outcome of the redemption of the TO1 warrants will be announced via press release as soon as possible and is expected to take place a few days after the end of the subscription period.

As soon as the issue has been registered with the Swedish Companies Registration Office and Euroclear, interim shares (IA) will be converted into ordinary shares and admitted to trading on the Nasdaq First North Growth Market.

Subscription price calculated and fixed

The subscription price for TO1 was fixed on 27 January 2023 at 3.37 SEK.

Financial advisor and underwriter

Skills Corporate Finance Nordic AB is the financial advisor and Nordic Issuing Fondkommission AB is the issuing agent to Realheart in connection with the exercise of warrants of series TO1.

The warrants, with ISIN code SE0016589246, are traded on Nasdaq First North Growth Market. For more information on the warrants of series TO1, please contact Nordic Issuing.

Link to document for full terms and conditions (in Swedish):

For more information please contact:

Ina Laura Perkins, CEO

Phone: +46(0)70 406 49 21 

E-mail: inalaura.perkins@realheart.se

Certified Adviser: Svensk Kapitalmarknadsgranskning AB, www.skmg.se

Scandinavian Real Heart AB develops a total artificial heart (TAH) for implantation in patients with life-threatening heart failure. Realheart® TAH has a patented design that resembles that of the natural human heart. The artificial heart consists of a four-chamber system (two atria and two ventricles) designed to generate a physiological blood flow pattern that mimics the body's natural circulation. A unique concept in the medical technology world.

https://news.cision.com/real-heart/r/information-on-trading-and-exercise-of-warrants-of-series-to1-in-realheart,c3705722

https://mb.cision.com/Main/12118/3705722/1814711.pdf

https://mb.cision.com/Public/12118/3705722/a64d116b5047f47d.pdf

(c) 2023 Cision. All rights reserved., source Press Releases - English